| 1. |
From the Editor |
| |
Inpharma Weekly,
Volume &NA;,
Issue 994,
1995,
Page 2-2
&NA;,
Preview
|
PDF (1168KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 2. |
Significant developments in ovarian, breast and lung cancer therapy |
| |
Inpharma Weekly,
Volume &NA;,
Issue 994,
1995,
Page 3-5
Franco M Muggia,
Preview
|
PDF (3141KB)
|
|
摘要:
Taxanes were a hot topic during sessions on ovarian, breast and lung cancer at the 31st Annual Meeting of the American Society of Clinical Oncology [Los Angeles, US; May 1995]. Some of the studies presented are likely to have considerable implications for the way cancer is treated today. For example, a combination of paclitaxel + cisplatin may replace conventional cyclophosphamide + cisplatin therapy in ovarian cancer. Another interesting development involves the use of a 96-hour infusion of paclitaxel in patients with breast cancer. Dr Franco M Muggia from the University of Southern California/Norris Comprehensive Cancer Center draws attention to such significant developments and, in so doing, provides a clearer picture of where current research should be heading.
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 3. |
New findings suggest novel approaches for prevention of miscarriage |
| |
Inpharma Weekly,
Volume &NA;,
Issue 994,
1995,
Page 5-5
&NA;,
Preview
|
PDF (1014KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 4. |
Antidepressant use linked to greater healthcare consumption |
| |
Inpharma Weekly,
Volume &NA;,
Issue 994,
1995,
Page 6-6
&NA;,
Preview
|
PDF (1003KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 5. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 994,
1995,
Page 7-7
&NA;,
Preview
|
PDF (1105KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 6. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 994,
1995,
Page 8-8
&NA;,
Preview
|
PDF (1045KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 7. |
Cytokine antagonism: still a main attraction in rheumatology R&D |
| |
Inpharma Weekly,
Volume &NA;,
Issue 994,
1995,
Page 9-10
Gill Higgins,
Preview
|
PDF (2126KB)
|
|
摘要:
Referred to as‘one of the fastest growing areas of research over the past decade’, the study of cytokines certainly appears to be holding its ground. Numerous presentations at the 13th European Congress of Rheumatology [Amsterdam, The Netherlands; June 1995] bore testimony to the sustained interest in developing cytokine antagonists as therapy for autoimmune diseases. At present, the greatest potential appears to lie with antibodies to tumour necrosis factor-&agr; (TNF-&agr;) and the use of soluble receptors for TNF-&agr; and interleukin-1 (IL-1).
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 8. |
Update on HIV research |
| |
Inpharma Weekly,
Volume &NA;,
Issue 994,
1995,
Page 11-11
&NA;,
Preview
|
PDF (1065KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 9. |
Interferon-&agr; recommended for maintenance of multiple myeloma |
| |
Inpharma Weekly,
Volume &NA;,
Issue 994,
1995,
Page 12-12
&NA;,
Preview
|
PDF (1053KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 10. |
Treatment of NIDDM: current practice and new drug development |
| |
Inpharma Weekly,
Volume &NA;,
Issue 994,
1995,
Page 13-15
Gill Higgins,
Preview
|
PDF (3092KB)
|
|
摘要:
Hyperglycaemia is the principal enemy in non-insulin-dependent diabetes mellitus (NIDDM). According to Dr James R Gavin from the Howard Hughes Medical Institute, Maryland, US,‘the enemy has been surrounded by currently available drugs’, but there is still plenty of room for improvement [see figure 1]. Dr Gavin discussed some of the key developments in today's treatment options for patients with NIDDM at the 55th Scientific Sessions of the American Diabetes Association [Atlanta, US; June 1995], and during other presentations, new leads on targets for drug development were reported.
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
首页
